Here we performed a comprehensive analysis to characterize genetic and acquired FH-FHR abnormalities in a large cohort of 199 C3G/IC-MPGN patients, classified into four clusters, with the main focus on CFH-CFHR CNVs. The gene discussed is CFH; the disease is familial hyperaldosteronism.